$11.09
Insights on American Vanguard Corp
Revenue is up for the last 4 quarters, 124.88M → 172.18M (in $), with an average increase of 10.1% per quarter
Netprofit is up for the last 3 quarters, -1.05M → 6.97M (in $), with an average increase of 164.3% per quarter
In the last 1 year, Cf Industries Holdings, Inc. has given 3.7% return, outperforming this stock by 50.5%
In the last 3 years, Cf Industries Holdings, Inc. has given 64.4% return, outperforming this stock by 108.9%
0.0%
Downside
Day's Volatility :2.63%
Upside
2.63%
24.53%
Downside
52 Weeks Volatility :59.86%
Upside
46.81%
Period | American Vanguard Corp | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | 15.83% | 8.3% | 0.0% |
6 Months | 9.84% | 15.4% | 0.0% |
1 Year | -46.84% | 8.9% | -1.5% |
3 Years | -44.67% | 7.7% | -21.8% |
Market Capitalization | 334.3M |
Book Value | $12.87 |
Dividend Share | 0.12 |
Dividend Yield | 1.03% |
Earnings Per Share (EPS) | 0.26 |
PE Ratio | 44.62 |
PEG Ratio | 2.27 |
Wall Street Target Price | 18.0 |
Profit Margin | 1.3% |
Operating Margin TTM | 7.02% |
Return On Assets TTM | 1.95% |
Return On Equity TTM | 2.03% |
Revenue TTM | 579.4M |
Revenue Per Share TTM | 20.6 |
Quarterly Revenue Growth YOY | 7.9% |
Gross Profit TTM | 241.4M |
EBITDA | 46.8M |
Diluted Eps TTM | 0.26 |
Quarterly Earnings Growth YOY | 0.78 |
EPS Estimate Current Year | 0.77 |
EPS Estimate Next Year | 0.85 |
EPS Estimate Current Quarter | 0.27 |
EPS Estimate Next Quarter | 0.07 |
What analysts predicted
Upside of 62.31%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 454.3M | ↑ 27.95% |
Net Income | 24.2M | ↑ 19.34% |
Net Profit Margin | 5.33% | ↓ 0.38% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 468.2M | ↑ 3.06% |
Net Income | 13.6M | ↓ 43.79% |
Net Profit Margin | 2.91% | ↓ 2.42% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 458.7M | ↓ 2.03% |
Net Income | 15.2M | ↑ 12.07% |
Net Profit Margin | 3.32% | ↑ 0.41% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 556.9M | ↑ 21.4% |
Net Income | 18.6M | ↑ 21.95% |
Net Profit Margin | 3.34% | ↑ 0.02% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 609.6M | ↑ 9.47% |
Net Income | 27.4M | ↑ 47.44% |
Net Profit Margin | 4.5% | ↑ 1.16% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 579.4M | ↓ 4.96% |
Net Income | 7.5M | ↓ 72.56% |
Net Profit Margin | 1.3% | ↓ 3.2% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 152.1M | ↑ 2.72% |
Net Income | 6.7M | ↓ 1.3% |
Net Profit Margin | 4.43% | ↓ 0.18% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 160.0M | ↑ 5.17% |
Net Income | 3.9M | ↓ 42.17% |
Net Profit Margin | 2.44% | ↓ 1.99% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 124.9M | ↓ 21.94% |
Net Income | 1.9M | ↓ 50.8% |
Net Profit Margin | 1.54% | ↓ 0.9% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 132.8M | ↑ 6.33% |
Net Income | -1.1M | ↓ 154.9% |
Net Profit Margin | -0.79% | ↓ 2.33% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 149.5M | ↑ 12.6% |
Net Income | -325.0K | ↓ 69.14% |
Net Profit Margin | -0.22% | ↑ 0.57% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 172.2M | ↑ 15.16% |
Net Income | 7.0M | ↓ 2247.38% |
Net Profit Margin | 4.05% | ↑ 4.27% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 593.6M | ↑ 10.83% |
Total Liabilities | 264.4M | ↑ 14.8% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 670.1M | ↑ 12.89% |
Total Liabilities | 325.9M | ↑ 23.3% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 667.2M | ↓ 0.43% |
Total Liabilities | 306.4M | ↓ 5.98% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 694.2M | ↑ 4.04% |
Total Liabilities | 321.4M | ↑ 4.89% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 726.3M | ↑ 4.63% |
Total Liabilities | 356.3M | ↑ 10.86% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 799.4M | ↑ 10.06% |
Total Liabilities | 429.4M | ↑ 20.5% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 776.2M | ↑ 4.37% |
Total Liabilities | 413.6M | ↑ 15.27% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 726.3M | ↓ 6.42% |
Total Liabilities | 356.3M | ↓ 13.85% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 771.1M | ↑ 6.16% |
Total Liabilities | 396.1M | ↑ 11.15% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 772.7M | ↑ 0.21% |
Total Liabilities | 403.6M | ↑ 1.89% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 802.8M | ↑ 3.91% |
Total Liabilities | 444.1M | ↑ 10.05% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 799.4M | ↓ 0.43% |
Total Liabilities | 429.4M | ↓ 3.33% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 11.3M | ↓ 80.77% |
Investing Cash Flow | -27.7M | ↓ 69.06% |
Financing Cash Flow | 11.1M | ↓ 67.19% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 9.4M | ↓ 17.12% |
Investing Cash Flow | -54.8M | ↑ 97.99% |
Financing Cash Flow | 46.4M | ↑ 316.83% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 89.2M | ↑ 848.6% |
Investing Cash Flow | -35.8M | ↓ 34.72% |
Financing Cash Flow | -43.2M | ↓ 193.12% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 87.3M | ↓ 2.11% |
Investing Cash Flow | -20.0M | ↓ 44.01% |
Financing Cash Flow | -65.9M | ↑ 52.44% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 57.1M | ↓ 34.6% |
Investing Cash Flow | -14.5M | ↓ 27.8% |
Financing Cash Flow | -38.3M | ↓ 41.92% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -18.4M | ↓ 462.79% |
Investing Cash Flow | -3.3M | ↑ 36.6% |
Financing Cash Flow | 19.8M | ↑ 666.87% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 102.8M | ↓ 657.15% |
Investing Cash Flow | -4.5M | ↑ 35.83% |
Financing Cash Flow | -98.1M | ↓ 595.99% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -41.5M | ↓ 140.33% |
Investing Cash Flow | -3.3M | ↓ 26.36% |
Financing Cash Flow | 43.8M | ↓ 144.64% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -55.2M | ↑ 33.05% |
Investing Cash Flow | -7.2M | ↑ 116.81% |
Financing Cash Flow | 54.3M | ↑ 24.06% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -49.3M | ↓ 10.69% |
Investing Cash Flow | -9.1M | ↑ 27.55% |
Financing Cash Flow | 48.6M | ↓ 10.52% |
Sell
Neutral
Buy
American Vanguard Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
American Vanguard Corp | -3.59% | 9.84% | -46.84% | -44.67% | -35.67% |
Fmc Corp. | -15.14% | -15.27% | -55.04% | -50.31% | -29.88% |
Nutrien Ltd. | -3.72% | -15.55% | -29.9% | -3.97% | -4.09% |
Corteva, Inc. | -2.16% | 4.49% | -14.99% | 12.65% | 84.59% |
Cf Industries Holdings, Inc. | -9.51% | -8.19% | 3.65% | 65.85% | 72.35% |
Mosaic Company, The | -5.99% | -17.42% | -34.49% | -7.45% | 11.9% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
American Vanguard Corp | 44.62 | 44.62 | 2.27 | 0.77 | 0.02 | 0.02 | 0.01 | 12.87 |
Fmc Corp. | 4.9 | 4.9 | 1.85 | 3.79 | 0.36 | 0.04 | 0.04 | 35.35 |
Nutrien Ltd. | 20.42 | 20.42 | NA | 3.95 | 0.05 | 0.04 | 0.04 | 50.87 |
Corteva, Inc. | 41.02 | 41.02 | 2.35 | 2.83 | 0.04 | 0.03 | 0.01 | 35.7 |
Cf Industries Holdings, Inc. | 9.92 | 9.92 | 0.64 | 6.12 | 0.23 | 0.1 | 0.03 | 30.38 |
Mosaic Company, The | 8.69 | 8.69 | 0.2 | 3.04 | 0.1 | 0.03 | 0.03 | 37.92 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
American Vanguard Corp | Buy | $334.3M | -35.67% | 44.62 | 1.3% |
Fmc Corp. | Buy | $7.1B | -29.88% | 4.9 | 29.45% |
Nutrien Ltd. | Buy | $25.9B | -4.09% | 20.42 | 4.48% |
Corteva, Inc. | Buy | $37.3B | 84.59% | 41.02 | 4.27% |
Cf Industries Holdings, Inc. | Buy | $14.7B | 72.35% | 9.92 | 23.0% |
Mosaic Company, The | Hold | $9.8B | 11.9% | 8.69 | 8.51% |
BlackRock Inc
Dimensional Fund Advisors, Inc.
Wellington Management Company LLP
Vanguard Group Inc
Cruiser Capital Advisors, LLC
Millennium Management LLC
In the quarter ending March,2024. American Vanguard Corp has declared dividend of $0.03
Read Moreamerican vanguard corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the united states and internationally. the company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. it also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as pcnb, chlorothalonil, and propiconazole under the ffii and ffiii names. the company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. american vanguard corporation was founded in 196
Organization | American Vanguard Corp |
Employees | 845 |
CEO | Mr. Eric G. Wintemute |
Industry | Process Industries |